UK markets closed

CMG Pharmaceutical Co., Ltd. (058820.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
2,115.00-10.00 (-0.47%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
93,906,675
93,906,675
82,197,410
69,475,496
64,459,891
Cost of revenue
50,203,948
50,203,948
41,295,950
36,024,850
33,249,439
Gross profit
43,702,727
43,702,727
40,901,460
33,450,645
31,210,452
Operating expenses
Research development
2,180,869
2,180,869
3,311,509
3,261,605
3,089,681
Selling general and administrative
18,858,521
18,858,521
17,212,584
14,327,839
12,102,012
Total operating expenses
40,665,786
40,665,786
37,920,064
31,790,169
29,388,087
Operating income or loss
3,036,941
3,036,941
2,981,396
1,660,476
1,822,365
Interest expense
79,543
79,543
15,277
20,695
22,853
Income before tax
6,731,033
6,731,033
-1,255,097
3,549,107
568,837
Income tax expense
275,684
275,684
-866,957
383,622
353,841
Income from continuing operations
6,455,349
6,455,349
-388,140
3,165,485
214,996
Net income
6,455,349
6,455,349
-388,140
3,165,485
214,996
Net income available to common shareholders
6,455,349
6,455,349
-388,140
3,165,485
214,996
Basic EPS
-3.00
-
-3.00
23.00
2.00
Diluted EPS
-3.00
-
-3.00
23.00
2.00
Basic average shares
129,380
-
129,380
137,630
138,892
Diluted average shares
129,380
-
129,380
137,630
138,892